user fees

Public Comment of Generation Patient, National Center for Health Research, Patient Safety Action Network, and USA Patient Network in response to the Medical Device User Fees Amendments (MDUFA) VI Stakeholders Process and Commitment Letter

August 7, 2026. In response to a request for public comments by the FDA on proposed recommendations for reauthorizing the Medical Device User Fee Amendments (MDUFA) VI for fiscal years 2028–2032, four members of the Patient, Consumer, and Public Health Coalition that attended the FDA Stakeholders meeting urged the FDA to strengthen patient safety with resources for post-market surveillance, safety metrics, ensuring that studies represent all patients, and ensure FDA staff can focus their resources on rigorous review of medical devices.

Public Comment of Generation Patient, National Center for Health Research, Patient Safety Action Network, and USA Patient Network in response to the Medical Device User Fees Amendments (MDUFA) VI Stakeholders Process and Commitment Letter Read More »

Coalition Letter To Senate HELP And Energy And Commerce Committee On User Fee Reauthorization Legislation

It is critically important that House and Senate committees work together to consolidate differences between the Food and Drug Amendments Act (H.R. 7667), which passed the House of Representatives on June 8, and the Food and Drug Administration Safety and Landmark Advancements Act (S. 4348), which passed the Senate Health, Education, Labor, and Pensions (HELP) Committee on June 15.

Coalition Letter To Senate HELP And Energy And Commerce Committee On User Fee Reauthorization Legislation Read More »